Excellent mate!Happy New Year

First 4 Last

Share
Profile

Follow
Zt3v3z

78 Posts.

41

26/12/21

19:48

Post #: 58523486
Share

Originally posted by That Fundamental Guy: ↑

Thanks to@jb7for posting the link to Bryan’s interview. Worth a listen for both long term and new shareholders.

https://www.boardroom.media/broadcast?eid=61c3da5ba7a4e1001c6e238b

Whilst the primary focus was about the recent equity packageannouncement, from about the 11 minute mark there were a few indications of newyear news flow.

Below is my quick summary of what we can expect in the new year.

Drilling – completed around end of January early February.Third drilling contractor on site from 4th of January to make up for delays from rain.So they are doing everything possible to stay on track with timing and adapting when necessary.

Resource upgrade – no specific timing, but presumably within a month orso from completion of drilling (happy to be guided by others with more experienceabout the time to test all drill cores and build the resource model).

Engineering partners – Currently talking with engineering partners to makeselection so when resource upgrade completed that the mining design work cancommence.

Transport options – “In January/February we will be very clear about theoptimum path to take our product to market”.

Capital stack – whilst no clear timing, it is clear that HIO’s intentionwill be to continue to complete deals that will contribute to the funding ofconstruction.These announcement will be critical in my opinion.Many have said (including myself) that construction funding is the most significant risk for HIO. As HIO delivers further funding announcements, the market will gain more confidence that a small CAP like HIO can raise $2B because of the quality of the project.

Happy new year to all holders.

Expand

Excellent mate!

Happy New Year

HIO Price at posting: 13.5¢ Sentiment: None Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 26 more messages in this thread...

First 4 Last

Add HIO (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change -0.001(4.35%)		Mkt cap ! $23.37M

Open	High	Low	Value	Volume
2.3¢	2.3¢	2.2¢	$2.029K	89.02K

Buyers (Bids)

No.	Vol.	Price($)
6	236755	2.2¢

Sellers (Offers)

Price($)	Vol.	No.
2.4¢	159875	1

View Market Depth

No.	Vol.	Price($)
6	236755	0.022
7	454000	0.021
17	4198186	0.020
3	123735	0.019
4	3276776	0.018

Price($)	Vol.	No.
0.024	159875	1
0.025	291897	2
0.026	692826	2
0.028	746290	3
0.029	456257	3

Last trade - 15.28pm 07/10/2024 (20 minute delay)

HIO (ASX) Chart

Excellent mate!Happy New Year

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Excellent mate!Happy New Year

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News